Aim:This clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients.Methods:A comprehensive literature search was conducted from November 11, 2017, to May 1, 2020, encompassing randomized and nonrandomized trials, observational studies, registries, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Additional relevant studies, published through April 2021, were also considered.Structure:Chest pain is a frequent cause for emergency department visits in the United States. The “2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain” provides recommendations based on contemporary evidence on the assessment and evaluation of chest pain. This guideline presents an evidence-based approach to risk stratification and the diagnostic workup for the evaluation of chest pain. Cost-value considerations in diagnostic testing have been incorporated, and shared decision-making with patients is recommended.

中文翻译：

---

2021 年 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估和诊断指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告


目的：这份胸痛评估和诊断的临床实践指南为临床医生评估和诊断成人患者胸痛提供建议和算法。方法：对2017年11月11日至2020年5月1日进行了全面的文献检索，包括对人类受试者进行的随机和非随机试验、观察性研究、登记、综述和其他证据，这些证据以英文形式发表在 PubMed、EMBASE、Cochrane Collaboration、医疗保健研究和质量报告机构以及其他相关数据库中。还考虑了截至 2021 年 4 月发表的其他相关研究。结构：胸痛是美国急诊科就诊的常见原因。 《2021 年 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估和诊断指南》根据当代证据对胸痛的评估和评估提供了建议。本指南提出了一种基于证据的风险分层方法和评估胸痛的诊断检查方法。已纳入诊断测试中的成本价值考虑因素，并建议与患者共同决策。